The company’s ACC lineup underscores a growing body of evidence backing the drug’s performance beyond controlled trials
It promises fewer injections for vision loss patients
Call it a major breakthrough for diagnostic imaging
The patent protects antiviral compounds developed by the company that inhibit Vacuolar ATPase (V-ATPase) activity in cells, a mechanism involved in viral infection pathways
This follows a $6 million expansion in Rosenberg in 2025 and signals a major push to boost commercial capacity, expand R&D capabilities, and meet rising demand for US-based drug product manufacturing
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
The Clear Lake facility marks Clariant’s first U.S. site dedicated to PEG excipient production
These upgrades will enable advanced development and flexible manufacturing, supporting complex therapeutics and meeting global demand for advanced pharmaceutical solutions
The partnership will focus on advancing fault-tolerant quantum algorithms and developing clinically relevant quantum applications
The deal also includes upfront licensing fees and milestone-based payments from Lupin to Zydus
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
